{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T02:58:20Z","timestamp":1779245900887,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11926-024-01165-6","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T09:01:53Z","timestamp":1727082113000},"page":"450-458","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Treatment of Reactive Arthritis with Biological Agents"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-5520-5612","authenticated-orcid":false,"given":"Avarna","family":"Agarwal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8093-8303","authenticated-orcid":false,"given":"Debashis","family":"Maikap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2545-9032","authenticated-orcid":false,"given":"Prasanta","family":"Padhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,23]]},"reference":[{"issue":"1","key":"1165_CR1","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jaad.2008.02.047","volume":"59","author":"IB Wu","year":"2008","unstructured":"Wu IB, Schwartz RA. Reiter\u2019s syndrome: the classic triad and more. J Am Academy of Dermatol. 2008;59(1):113\u201321. https:\/\/doi.org\/10.1016\/j.jaad.2008.02.047.","journal-title":"J Am Academy of Dermatol"},{"issue":"4","key":"1165_CR2","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1136\/ard.60.4.337","volume":"60","author":"C Fendler","year":"2001","unstructured":"Fendler C, Laitko S, S\u00f6rensen H, Gripenberg-Lerche C, Groh A, Uksila J, Granfors K, Braun J, Sieper J. Frequency of triggering bacteria in patients with reactive arthritis and undifferentiated oligoarthritis and the relative importance of the tests used for diagnosis. Ann Rheum Dis. 2001;60(4):337\u201343. https:\/\/doi.org\/10.1136\/ard.60.4.337.","journal-title":"Ann Rheum Dis"},{"issue":"4\u20135","key":"1165_CR3","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.autrev.2014.01.005","volume":"13","author":"C Selmi","year":"2014","unstructured":"Selmi C, Gershwin ME. Diagnosis and classification of reactive arthritis. Autoimmun Rev. 2014;13(4\u20135):546\u20139. https:\/\/doi.org\/10.1016\/j.autrev.2014.01.005.","journal-title":"Autoimmun Rev"},{"issue":"6","key":"1165_CR4","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1136\/ard.2009.108233","volume":"68","author":"MV Rudwaleit","year":"2009","unstructured":"Rudwaleit MV, Van Der Heijde D, Landew\u00e9 R, Listing J, Akkoc N, Brandt J, Braun J, Chou CT, Collantes-Estevez E, Dougados M, Huang F. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009;68(6):777\u201383. https:\/\/doi.org\/10.1136\/ard.2009.108233.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1165_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1136\/ard.2010.133645","volume":"70","author":"MV Rudwaleit","year":"2011","unstructured":"Rudwaleit MV, van der Heijde D, Landew\u00e9 R, Akkoc N, Brandt J, Chou CT, Dougados M, Huang F, Gu J, Kirazli Y, Van den Bosch F. The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann rheum Dis. 2011;70(1):25\u201331. https:\/\/doi.org\/10.1136\/ard.2010.133645.","journal-title":"Ann rheum Dis"},{"issue":"5","key":"1165_CR6","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s11926-996-0012-8","volume":"3","author":"J Sieper","year":"2001","unstructured":"Sieper J. Pathogenesis of reactive arthritis. Curr Rheumatol Rep. 2001;3(5):412\u20138. https:\/\/doi.org\/10.1007\/s11926-996-0012-8.","journal-title":"Curr Rheumatol Rep"},{"issue":"4","key":"1165_CR7","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.idc.2006.09.004","volume":"20","author":"JD Carter","year":"2006","unstructured":"Carter JD. Reactive arthritis: defined etiologies, emerging pathophysiology, and unresolved treatment. Infect Dis Clin. 2006;20(4):827\u201347. https:\/\/doi.org\/10.1016\/j.idc.2006.09.004.","journal-title":"Infect Dis Clin"},{"issue":"1","key":"1165_CR8","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ajem.2012.04.019","volume":"31","author":"CM Ngaruiya","year":"2012","unstructured":"Ngaruiya CM, Martin IB. A case of reactive arthritis: a great masquerader. Am J Emerg Med. 2012;31(1):266-e5. https:\/\/doi.org\/10.1016\/j.ajem.2012.04.019.","journal-title":"Am J Emerg Med"},{"issue":"10","key":"1165_CR9","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1002\/art.1780401010","volume":"40","author":"Z Yin","year":"1997","unstructured":"Yin Z, Braun J, Neure L, Wu P, Liu L, Eggens U, Sieper J. Crucial role of interleukin-10\/interleukin-12 balance in the regulation of the type 2 T helper cytokine response in reactive arthritis. Arthr Rheum. 1997;40(10):1788\u201397. https:\/\/doi.org\/10.1002\/art.1780401010.","journal-title":"Arthr Rheum"},{"key":"1165_CR10","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s10067-008-1011-0","volume":"28","author":"D Wendling","year":"2009","unstructured":"Wendling D, Cedoz JP, Racadot E. Serum and synovial fluid levels of p40 IL12\/23 in spondyloarthropathy patients. Clin Rheumatol. 2009;28:187\u201390. https:\/\/doi.org\/10.1007\/s10067-008-1011-0.","journal-title":"Clin Rheumatol"},{"issue":"6; SUPP\/28","key":"1165_CR11","first-page":"S-130","volume":"20","author":"R Meador","year":"2002","unstructured":"Meador R, Hsia E, Kitumnuaypong T, Schumacher HR. TNF involvement and anti-TNF therapy of reactive and unclassified arthritis. Clin Exp Rheumatol. 2002;20(6; SUPP\/28):S-130.","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"1165_CR12","first-page":"2285","volume":"34","author":"R Singh","year":"2007","unstructured":"Singh R, Aggarwal A, Misra R. Th1\/Th17 cytokine profiles in patients with reactive arthritis\/undifferentiated spondyloarthropathy. J Rheumatol. 2007;34(11):2285\u201390.","journal-title":"J Rheumatol"},{"issue":"5","key":"1165_CR13","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/j.1365-2362.1991.tb01398.x","volume":"21","author":"I Holt","year":"1991","unstructured":"Holt I, Cooper RG, Hopkins SJ. Relationships between local inflammation, interleukin-6 concentration and the acute phase protein response in arthritis patients. Eur J Clin Investig. 1991;21(5):479\u201384. https:\/\/doi.org\/10.1111\/j.1365-2362.1991.tb01398.x.","journal-title":"Eur J Clin Investig"},{"issue":"2","key":"1165_CR14","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/cei.12799","volume":"185","author":"S Chaurasia","year":"2016","unstructured":"Chaurasia S, Shasany AK, Aggarwal A, Misra R. Recombinant Salmonella typhimurium outer membrane protein A is recognized by synovial fluid CD8 cells and stimulates synovial fluid mononuclear cells to produce interleukin (IL)-17\/IL-23 in patients with reactive arthritis and undifferentiated spondyloarthropathy. Clin Exp Immunol. 2016;185(2):210\u20138. https:\/\/doi.org\/10.1111\/cei.12799.","journal-title":"Clin Exp Immunol"},{"issue":"12","key":"1165_CR15","doi-asserted-by":"publisher","first-page":"e82588","DOI":"10.1371\/journal.pone.0082588","volume":"8","author":"M Noto Llana","year":"2013","unstructured":"Noto Llana M, Sarnacki SH, Aya Casta\u00f1eda MD, Bernal MI, Giacomodonato MN, Cerquetti MC. Consumption of Lactobacillus casei fermented milk prevents Salmonella reactive arthritis by modulating IL-23\/IL-17 expression. PLoS One. 2013;8(12):e82588. https:\/\/doi.org\/10.1371\/journal.pone.0082588.","journal-title":"PLoS One."},{"issue":"1","key":"1165_CR16","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1093\/mrcr\/rxab014","volume":"6","author":"P Padhan","year":"2022","unstructured":"Padhan P, Maikap D. Secukinumab therapy in reactive arthritis: Report of two cases. Modern Rheumatol Case Rep. 2022;6(1):22\u20134. https:\/\/doi.org\/10.1093\/mrcr\/rxab014.","journal-title":"Modern Rheumatol Case Rep"},{"issue":"2","key":"1165_CR17","doi-asserted-by":"publisher","first-page":"227","DOI":"10.4103\/ijdvl.IJDVL_519_18","volume":"87","author":"V Gupta","year":"2021","unstructured":"Gupta V, Mohta P, Sharma VK, Khanna N. A retrospective case series of 12 patients with chronic reactive arthritis with emphasis on treatment outcome with biologics. Indian J Dermatol Venereol Leprol. 2021;87(2):227\u201334. https:\/\/doi.org\/10.4103\/ijdvl.IJDVL_519_18.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"1165_CR18","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1136\/annrheumdis-2020-eular.295","volume":"79","author":"S Ahmed","year":"2020","unstructured":"Ahmed S, Padhan P. AB0632 Effectiveness of etanercept biosimilars in reactive arthritis: retrospective case control. Ann Rheum Dis. 2020;79:1611\u20132. https:\/\/doi.org\/10.1136\/annrheumdis-2020-eular.295.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"1165_CR19","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1002\/art.40581","volume":"70","author":"LJ Van Mens","year":"2018","unstructured":"Van Mens LJ, van de Sande MG, Menegatti S, Chen S, Blijdorp IC, de Jong HM, Fluri IA, Latuhihin TE, van Kuijk AW, Rogge L, Yeremenko NG. Brief report: interleukin-17 blockade with secukinumab in peripheral spondyloarthritis impacts synovial immunopathology without compromising systemic immune responses. Arthr Rheumatol. 2018;70(12):1994\u20132002. https:\/\/doi.org\/10.1002\/art.40581.","journal-title":"Arthr Rheumatol"},{"issue":"2","key":"1165_CR20","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jbspin.2016.02.022","volume":"84","author":"A Brinster","year":"2017","unstructured":"Brinster A, Guillot X, Prati C, Wendling D. Anti-TNF treatment of reactive arthritis. A monocentric experience. Joint Bone Spine. 2017;84(2):237\u20138. https:\/\/doi.org\/10.1016\/j.jbspin.2016.02.022.","journal-title":"Joint Bone Spine"},{"key":"1165_CR21","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.annder.2017.08.004","volume":"144","author":"KC Ahogo","year":"2017","unstructured":"Ahogo KC, Bataille M, Lasek A, Wantz M, Lebas D, Modiano P. A case of reactive arthritis (oculo-urethro-synovial syndrome) treated with infliximab. Ann Dermatol Venereo. 2017;144:804\u20135. https:\/\/doi.org\/10.1016\/j.annder.2017.08.004.","journal-title":"Ann Dermatol Venereo"},{"key":"1165_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00296-011-2000-1","volume":"32","author":"A Edrees","year":"2012","unstructured":"Edrees A. Successful use of etanercept for the treatment of Reiter\u2019s syndrome: a case report and review of the literature. Rheumatol Int. 2012;32:1\u20133. https:\/\/doi.org\/10.1007\/s00296-011-2000-1.","journal-title":"Rheumatol Int"},{"issue":"3","key":"1165_CR23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/RHU.0b013e31824e9151","volume":"18","author":"NB Gaylis","year":"2012","unstructured":"Gaylis NB. Long-term follow-up of an HIV-infected patient with reactive arthritis treated with infliximab. JCR: J Clin Rheumatol. 2012;18(3):153\u20134. https:\/\/doi.org\/10.1097\/RHU.0b013e31824e9151.","journal-title":"JCR: J Clin Rheumatol"},{"issue":"5","key":"1165_CR24","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1002\/art.30272","volume":"63","author":"A Meyer","year":"2011","unstructured":"Meyer A, Chatelus E, Wendling D, Berthelot JM, Dernis E, Houvenagel E, Morel J, Richer O, Schaeverbeke T, Gottenberg JE, Sibilia J. Safety and efficacy of anti\u2013tumor necrosis factor \u03b1 therapy in ten patients with recent-onset refractory reactive arthritis. Arthr Rheum. 2011;63(5):1274\u201380. https:\/\/doi.org\/10.1002\/art.30272.","journal-title":"Arthr Rheum"},{"issue":"5","key":"1165_CR25","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00296-009-0965-9","volume":"30","author":"MD Schafranski","year":"2010","unstructured":"Schafranski MD. Infliximab for reactive arthritis secondary to Chlamydia trachomatis infection. Rheumatology international. 2010;30(5):679\u201380. https:\/\/doi.org\/10.1007\/s00296-009-0965-9.","journal-title":"Rheumatology international."},{"issue":"2","key":"1165_CR26","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/RHU.0b013e3181d06f70","volume":"16","author":"MD Wechalekar","year":"2010","unstructured":"Wechalekar MD, Rischmueller M, Whittle S, Burnet S. Hill CL 2010 Prolonged remission of chronic reactive arthritis treated with three infusions of infliximab. JCR: J Clin Rheumatol. 2010;16(2):79\u201380. https:\/\/doi.org\/10.1097\/RHU.0b013e3181d06f70.","journal-title":"JCR: J Clin Rheumatol"},{"issue":"12","key":"1165_CR27","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1002\/art.24899","volume":"61","author":"T Tanaka","year":"2009","unstructured":"Tanaka T, Kuwahara Y, Shima Y, Hirano T, Kawai M, Ogawa M, Arimitsu J, Hagihara K, Narazaki M, Ogata A, Kawase I. Successful treatment of reactive arthritis with a humanized anti\u2013interleukin-6 receptor antibody, tocilizumab. Arthr Care Res. 2009;61(12):1762\u20134. https:\/\/doi.org\/10.1002\/art.24899.","journal-title":"Arthr Care Res"},{"key":"1165_CR28","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s10067-007-0692-0","volume":"27","author":"H Gill","year":"2008","unstructured":"Gill H, Majithia V. Successful use of infliximab in the treatment of Reiter\u2019s syndrome: a case report and discussion. Clin Rheumatol. 2008;27:121\u20133. https:\/\/doi.org\/10.1007\/s10067-007-0692-0.","journal-title":"Clin Rheumatol"},{"issue":"3","key":"1165_CR29","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1097\/RHU.0b013e3180690c1f","volume":"13","author":"D S\u00e1nchez-Cano","year":"2007","unstructured":"S\u00e1nchez-Cano D, Callejas-Rubio JL, Ortego-Centeno N. Use of adalimumab in poststreptococcal reactive arthritis. JCR: J Clin Rheumatol. 2007;13(3):176. https:\/\/doi.org\/10.1097\/RHU.0b013e3180690c1f.","journal-title":"JCR: J Clin Rheumatol"},{"issue":"4","key":"1165_CR30","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/art.21323","volume":"53","author":"SD Flagg","year":"2005","unstructured":"Flagg SD, Meador R, Hsia E, Kitumnuaypong T, Schumacher HR Jr. Decreased pain and synovial inflammation after etanercept therapy in patients with reactive and undifferentiated arthritis: an open-label trial. Arthr Care Res: Off J Am Coll Rheumatol. 2005;53(4):613\u20137. https:\/\/doi.org\/10.1002\/art.21323.","journal-title":"Arthr Care Res: Off J Am Coll Rheumatol"},{"issue":"2","key":"1165_CR31","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1080\/03009740310000157","volume":"32","author":"O Kaipiainen-Sepp\u00e4nen","year":"2003","unstructured":"Kaipiainen-Sepp\u00e4nen O, Niinisalo H, Korpil\u00e4hde T, Virolainen J. Treatment of reactive arthritis with infliximab. Scandinavian J Rheumatol. 2003;32(2):122\u20134. https:\/\/doi.org\/10.1080\/03009740310000157.","journal-title":"Scandinavian J Rheumatol"},{"issue":"2","key":"1165_CR32","first-page":"407","volume":"30","author":"N Gaylis","year":"2003","unstructured":"Gaylis N. Infliximab in the treatment of an HIV positive patient with Reiter\u2019s syndrome. J Rheumatol. 2003;30(2):407\u201311.","journal-title":"J Rheumatol"},{"key":"1165_CR33","doi-asserted-by":"crossref","unstructured":"Maikap D, Padhan P. Successful use of tofacitinib in reactive arthritis refractory to conventional therapies\u2013a case series. Mod Rheumatol Case Rep. 2022;6(2):167\u201370.","DOI":"10.1093\/mrcr\/rxab029"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-024-01165-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11926-024-01165-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-024-01165-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T09:22:47Z","timestamp":1730366567000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11926-024-01165-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,23]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1165"],"URL":"https:\/\/doi.org\/10.1007\/s11926-024-01165-6","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,23]]},"assertion":[{"value":"4 September 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with animals performed by any of the authors. For studies involving human participants, written informed consent was obtained from all participants prior to their inclusion in the study. The consent form outlined the purpose of the study, the potential risks and benefits, and the participants' rights, including their right to withdraw at any time. Participants also provided consent for their data to be used in the study and potentially published, while maintaining their anonymity.\"","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}